Evidence map›Paper›PMID 26001754›Full record

ArticleMutagenesis2016

Quantitative analysis of the relative mutagenicity of five chemical constituents of tobacco smoke in the mouse lymphoma assay.

Xiaoqing Guo, Robert H Heflich, Stacey L Dial, Patricia A Richter, Martha M Moore, Nan Mei

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Mutagenesis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Benchmark Response (BMR) Values for In Vivo Mutagenicity Endpoints.Environmental and molecular mutagenesis · 2025
    Article
  4. Mutation accumulation following extended exposure of human HepaRG cells to a genotoxic carcinogen.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2025
    Article
  5. Optimizing the detection of N-nitrosamine mutagenicity in the Ames test.Regulatory toxicology and pharmacology : RTP · 2024
    Article
  6. Application of HepaRG cells for genotoxicity assessment: a review.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Benchmark Dose Modeling ofToxicological research · 2018
    Review
  12. Comparative Genotoxicity of TEMPO and 3 of Its Derivatives in Mouse Lymphoma Cells.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaoqing GuoDivision of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA and.
Robert H HeflichDivision of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA and.
Stacey L DialDivision of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA and.
Patricia A RichterCenter for Tobacco Products, Silver Spring, MD 20993, USA Present address: Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA 30341, USA;
Martha M MooreDivision of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA and Ramboll Environ, 124 West Capitol Avenue, Suite 1890, Little Rock, AR 72201, USA.
Nan MeiDivision of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA and nan.mei@fda.hhs.gov.
National Center for Toxicological Research · USCenters for Disease Control and Prevention · US

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Quantifying health-related biological effects, like genotoxicity, could provide a way of distinguishing between tobacco products. In order to develop tools for using genotoxicty data to quantitatively evaluate the risk of tobacco products, we tested five carcinogens found in cigarette smoke, 4-aminobiphenyl (4-ABP), benzo[a]pyrene (BaP), cadmium (in the form of CdCl2), 2-amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline (MeIQ) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the mouse lymphoma assay (MLA). The resulting mutagenicity dose responses were analyzed by various quantitative approaches and their strengths and weaknesses for distinguishing responses in the MLA were evaluated. L5178Y/Tk (+/-) 3.7.2C mouse lymphoma cells were treated with four to seven concentrations of each chemical for 4h. Only CdCl2 produced a positive response without metabolic activation (S9); all five chemicals produced dose-dependent increases in cytotoxicity and mutagenicity with S9. The lowest dose exceeding the global evaluation factor, the benchmark dose producing a 10%, 50%, 100% or 200% increase in the background frequency (BMD10, BMD50, BMD100 and BMD200), the no observed genotoxic effect level (NOGEL), the lowest observed genotoxic effect level (LOGEL) and the mutagenic potency expressed as a mutant frequency per micromole of chemical, were calculated for all the positive responses. All the quantitative metrics had similar rank orders for the agents' ability to induce mutation, from the most to least potent as CdCl2(-S9) > BaP(+S9) > CdCl2(+S9) > MeIQ(+S9) > 4-ABP(+S9) > NNK(+S9). However, the metric values for the different chemical responses (i.e. the ratio of the greatest value to the least value) for the different chemicals ranged from 16-fold (BMD10) to 572-fold (mutagenic potency). These results suggest that data from the MLA are capable of discriminating the mutagenicity of various constituents of cigarette smoke, and that quantitative analyses are available that can be useful in distinguishing between the exposure responses.

Indexed as

DNA DamageMutagenicity TestsActivation, MetabolicAminobiphenyl CompoundsAnimalsBenzo(a)pyreneCadmium ChlorideCarcinogensCell Line, TumorDNA, NeoplasmLymphomaMiceMutagensNitrosaminesQuinolinesRats2-amino-3,4-dimethylimidazo(4,5-f)quinoline4-biphenylamine4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneAminobiphenyl CompoundsBenzo(a)pyreneCadmium ChlorideCarcinogensDNA, NeoplasmMutagensNitrosaminesQuinolinesSmoke

Identifiers

PMID26001754
PMCPMC6419102
OpenAlexW2309591482

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.